Main Responsibilities of the National Medical Products Administration
(1) To supervise the safety of drugs (including traditional Chinese medicines (TCMs) and ethno-medicines, the same below), medical devices and cosmetics; to draw up regulatory policy plans, organize the drafting of laws and regulations, formulate normative documents, and supervise the implementation thereof; to research and formulate regulatory and supportive policies that encourage new technologies and new products for drugs, medical devices and cosmetics.
(2) To undertake standards management for drugs, medical devices and cosmetics; to organize the formulation and publication of the Chinese Pharmacopoeia and other drug and medical device standards, organize the drafting of cosmetic standards, organize the formulation of the classification management system, and supervise the implementation thereof; to participate in formulating the National Essential Medicine List, and assist in the implementation of the national essential medicine system.
(3) To regulate the registration of drugs, medical devices and cosmetics; to develop the registration system, conduct strict review and approval for marketing, improve measures to facilitate the review and approval process, and organize the implementation thereof.
(4) To undertake quality management for drugs, medical devices and cosmetics; to develop Good Laboratory Practices (GLP) and Good Clinical Practices (GCP), and supervise the implementation thereof; to develop Good Manufacturing Practices (GMP) and supervise the implementation thereof in line with NMPA’s responsibilities; to develop good practices on the distribution and use of medical products and guide the implementation thereof.
(5) To undertake post-market risk management for drugs, medical devices and cosmetics; to organize the monitoring, evaluation, and handling of adverse drug reactions, medical device adverse events, and cosmetic adverse reactions; to undertake emergency response management for drugs, medical devices and cosmetics in accordance with law.
(6) To undertake management of qualifications for licensed pharmacists; to formulate regulations of qualifications for licensed pharmacists, and guide and supervise the registration of licensed pharmacists.
(7) To organize and guide the supervision and inspection of drugs, medical devices and cosmetics; to develop the inspection system, investigate and punish illegal activities during the registration process for drugs, medical devices and cosmetics in accordance with law, and organize and guide the investigation and punishment of illegal activities during the manufacturing process in line with NMPA’s responsibilities.
(8) To engage in international exchange and cooperation in the regulation of drugs, medical devices and cosmetics, and participate in developing relevant international regulatory rules and standards.
(9) To guide the work of drug regulatory departments of all provinces, autonomous regions, and municipalities directly under the Central Government.
(10) To complete other tasks assigned by the CPC Central Committee and the State Council.
下一篇:原卫生部《进口非特殊用途化妆品备案凭证》 »
相关文章:
- [ABOUT]Cooperation Process of Imported Cosmetics Registration
- [ABOUT]Documents Preparation
- [ABOUT]Procedure
- [ABOUT]EVENTS
- [ABOUT]Commitments
- [ABOUT]Cooperation cases
- [ABOUT]Contact Us
- [ABOUT]Services
- [ABOUT]BeijingTianjianhuacheng International Investment Co.,Ltd
- [ABOUT]How to choose a professional agency?
相关推荐:
- [申报攻略]天津市进口非特殊用途化妆品备案服务指南
- [常见问题]化妆品备案注册申报时常见的原料配方问题
- [审批动态]2024年09月23日化妆品注册批准证明文件送达信息
- [审批动态]2021年12月31日保健食品批件(决定书)待领取信息-1
- [申报资讯]化妆品启用新标签 试用装也要用中文
- [帮助中心]委托你们申报能100%保证成功吗?你们和主管部门的关系怎么样?
- [审批动态]2023年11月08日化妆品注册决定书送达信息发布
- [流程周期]国产特殊用途化妆品审核程序、材料及费用(黑龙江省)
- [新食品原料]解读《关于关山樱花等32种“三新食品”的公告》(2022年第1号)
- [审批动态]2025年4月21日保健食品注册批件(决定书)待领取信息
-
86-010-84828041/42
400-6167-168
zhuceabc@zhuceabc.com
咨询微信:
13601366497(化妆品类)
1801335159(特殊食品类)







